United States · FDA National Drug Code directory
GRANIX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63459-910_063f36a7-6f99-40fa-af02-8a5183c51e99
- Product NDC
- 63459-910
- Form
- INJECTION, SOLUTION
- Composition / generic term
- tbo-filgrastim
- Labeler
- Cephalon, LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20131111
- Source listing expiry
- 20261231
Source-listed ingredients
- FILGRASTIM — 300 ug/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (63459-910-11) / 1 SYRINGE, GLASS in 1 BLISTER PACK (63459-910-12) / .5 mL in 1 SYRINGE, GLASS (63459-910-01) · 63459-910-11
- 10 BLISTER PACK in 1 CARTON (63459-910-15) / 1 SYRINGE, GLASS in 1 BLISTER PACK (63459-910-12) / .5 mL in 1 SYRINGE, GLASS (63459-910-01) · 63459-910-15
- 1 SYRINGE, GLASS in 1 CARTON (63459-910-17) / .5 mL in 1 SYRINGE, GLASS (63459-910-18) · 63459-910-17
- 5 SYRINGE, GLASS in 1 CARTON (63459-910-36) / .5 mL in 1 SYRINGE, GLASS (63459-910-18) · 63459-910-36
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →